These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3105046)

  • 1. The emergence of resistance of Pseudomonas aeruginosa in patients treated with ceftazidime.
    Foord RD; Butcher ME; Williams AH
    Scand J Infect Dis; 1987; 19(1):143. PubMed ID: 3105046
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudomonas aeruginosa resistance to ceftazidime.
    Balagué M; Del Valle O; Figueras A; Arnau JM
    DICP; 1991; 25(7-8):871. PubMed ID: 1949952
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa.
    Aubert D; Poirel L; Chevalier J; Leotard S; Pages JM; Nordmann P
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1615-20. PubMed ID: 11353602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipenem and ceftazidime resistance in Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Knothe H; Antal M; Krcméry V
    J Antimicrob Chemother; 1987 Jan; 19(1):136-8. PubMed ID: 3104275
    [No Abstract]   [Full Text] [Related]  

  • 5. Ceftazidime resistance in Pseudomonas aeruginosa: transduction by a wild-type phage.
    Seginková Z; Krcméry V; Knothe H
    J Infect Dis; 1986 Dec; 154(6):1049-50. PubMed ID: 3097161
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro interactions of gamma-linolenic acid and arachidonic acid with ceftazidime on multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Dionyssiou-Asteriou A; Giamarellou H
    Lipids; 1999; 34 Suppl():S151-2. PubMed ID: 10419130
    [No Abstract]   [Full Text] [Related]  

  • 7. Nosocomial infections with ceftazidime-resistant Pseudomonas aeruginosa: risk factors and outcome.
    Lee SC; Fung CP; Liu PY; Wang TC; See LC; Lee N; Chen SC; Shieh WB
    Infect Control Hosp Epidemiol; 1999 Mar; 20(3):205-7. PubMed ID: 10100550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Lactamase Id of ceftazidime-resistant Pseudomonas aeruginosa strains.
    Michel-Briand Y; Nicolas T; Godard C; Plesiat P
    Microbiologica; 1992 Jan; 15(1):65-9. PubMed ID: 1556960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of four methods for the determination of the susceptibility of 47 strains of Pseudomonas aeruginosa to ceftazidime and cefepime: influence of the choice of interpretative criteria].
    Boucaud-Maître Y; Thoinet S
    Pathol Biol (Paris); 1996 May; 44(5):363-6. PubMed ID: 8758477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.
    Watanabe N; Hiruma R; Katsu K
    J Antimicrob Chemother; 1992 Nov; 30(5):633-41. PubMed ID: 1493980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of some antibiotics against Pseudomonas aeruginosa strains isolated from cancerous patients.
    Del Piano M; Nicosia R; La Palombara P; Chiarini F
    Boll Ist Sieroter Milan; 1984 Jul; 63(3):181-7. PubMed ID: 6095882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
    Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(6):391-8. PubMed ID: 7842822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug resistance and floral distribution of Pseudomonas aeruginosa].
    Jia CY
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1990 Sep; 6(3):170-3, 236. PubMed ID: 2125852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of Ceftazidime-Avibactam against Clinical and Isogenic Laboratory Pseudomonas aeruginosa Isolates Expressing Combinations of Most Relevant β-Lactam Resistance Mechanisms.
    Torrens G; Cabot G; Ocampo-Sosa AA; Conejo MC; Zamorano L; Navarro F; Pascual Á; Martínez-Martínez L; Oliver A
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6407-10. PubMed ID: 27480848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New antimicrobial agent series XVII: Ceftazidime].
    Ishibiki K
    Jpn J Antibiot; 1986 Nov; 39(11):2819-30. PubMed ID: 3102806
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activity of ceftazidime and other beta-lactam antibiotics against nosocomial strains of Pseudomonas aeruginosa.
    Santos Ferreira MO; Bacelar MJ; Canica MM
    J Int Med Res; 1984; 12(6):356-60. PubMed ID: 6440822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential resistance of hospital Pseudomonas aeruginosa to ceftazidime, imipenem or aztreonam.
    Krcméry V; Antal M; Menkyna R; Knothe H; Schäfer V
    J Chemother; 1989 Jul; 1(4 Suppl):364-5. PubMed ID: 16312441
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.
    Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of ceftazidime on enterobacteria and Pseudomonas producers of beta-lactamases].
    Chabbert YA; Derlot E; Courvalin P
    Pathol Biol (Paris); 1985 Sep; 33(7):758-63. PubMed ID: 3936006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transduction of resistance to Imipenem, Aztreonam and Ceftazidime in nosocomial strains of Pseudomonas aeruginosa by wild-type phages.
    Blahová J; Hupková M; Babálová M; Krcméry V; Schäfer V
    Acta Virol; 1993 Dec; 37(6):429-36. PubMed ID: 8010181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.